Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Klarify is a digital health brand and platform developed by ALK-Abelló, a global leader in allergy immunotherapy. The platform is designed to empower allergy sufferers by providing comprehensive tools for symptom management, including a mobile application that tracks pollen levels, air quality, and weather conditions. Additionally, Klarify offers home-based IgE allergy testing kits that allow users to identify specific triggers from their own homes. By integrating diagnostic data with real-time environmental tracking, Klarify aims to bridge the gap between initial symptom awareness and professional clinical treatment, ultimately improving the quality of life for individuals with respiratory and food allergies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Klarify.